| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 614,957 | 554,612 | 681,040 | 729,881 | | Cost of Revenue | 489,290 | 467,521 | 547,126 | 533,663 | | | Gross Profit | 125,667 | 87,091 | 133,914 | 196,218 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,412 | 5,753 | 28,464 | 26,184 | | Non Recurring | 7,777 | 5,552 | (6,163) | (58,208) | | Others | 71,468 | 68,477 | 73,041 | 141,004 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 48,338 | 7,309 | 38,572 | 87,238 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,727 | 417 | 6,468 | 10,726 | | Earnings Before Interest And Taxes | 48,737 | 7,726 | 45,040 | 97,964 | | Interest Expense | 29,791 | 20,657 | 20,018 | 19,911 | | Income Before Tax | 18,946 | (12,931) | 25,022 | 78,053 | | Income Tax Expense | (6,270) | 2,230 | (5,550) | 15,715 | | Minority Interest | 11 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 25,227 | (15,161) | 30,572 | 62,338 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 25,227 | (15,161) | 30,572 | 62,338 | | Preferred Stock And Other Adjustments | (42) | 35 | 7 |
-
| | | Net Income Applicable To Common Shares | $25,185 | ($15,126) | $30,579 | $62,338 |
|
1.48% Nasdaq 
Income Statement
